In short. How to tell whether a risk conversation is complete, what informed consent should cover, and the complications you are entitled to hear about before deciding.

Key points

  • A complete conversation covers what happens in the first week, what happens over a lifetime, and what happens if the result is not what you wanted.
  • If any of those three is missing, the rest is unreliable.
  • You are entitled to ask how each risk would be managed at this hospital, not only that it exists.

A risk conversation is not a list read aloud for signature. It is the point at which you find out what you are accepting, and it is the only part of the process you cannot delegate to the surgeon. If it is short, vague, or framed as unlikely to matter, that says something about the clinic rather than the risk.

The risks that belong to having a device

Capsular contracture, the tightening of the scar tissue the body forms around any implant, which can make the breast firm, distorted or uncomfortable and often requires an operation to correct. Rupture, which is frequently silent. And reoperation: over a lifetime, a further operation should be treated as likely rather than merely possible.

The risks that belong to the operation

Infection, bleeding and fluid collection around the device, wound problems, changes in nipple or breast sensation that may be permanent, scarring, asymmetry, and dissatisfaction with the size or shape of the result. Anaesthesia carries its own risks, which depend on your health and are why a preoperative assessment exists. None of these is rare enough to be omitted.

How to tell whether the list is complete

A complete conversation covers what happens in the first week, what happens over a lifetime, and what happens if the result is not what you wanted. If any of those three is missing, the rest is unreliable. You are entitled to ask how each risk would be managed at this hospital, not only that it exists.

The rare and serious ones

A small number of serious complications are uncommon but must be named. One is a rare cancer of the tissue around the breast, associated with implants and more often reported with textured surfaces. It usually presents as swelling or a fluid collection appearing long after the operation, and it is treated by removing the device and the surrounding tissue. It is rare, and it is not by itself a reason to refuse an implant, but it is a reason to attend surveillance and report a late change.

Risks that are yours rather than the operation’s

Smoking, which impairs healing and raises infection and clot risk. Weight change and pregnancy, which alter the result over time. And not attending follow-up, which converts a manageable finding into a late one. These are not complications of surgery; they are the parts of the outcome that depend on you, and they deserve to be said out loud.

Ask again, or elsewhere, if

  • The complications discussed stop at the first few weeks, with nothing about the lifetime of a device.
  • The consent form is presented for signature before the conversation, rather than after it.
  • You are told a risk is too rare to worry about, without being told what it is.

What you are actually agreeing to

You are agreeing to an operation with a defined recovery, a result that cannot be guaranteed, a device that will probably need attention eventually, and a commitment to surveillance. Both the benefit and the limits are fixed before the operation; only the outcome is unknown. That understanding is what makes consent meaningful rather than procedural. The operation does not fix a relationship, a mood, or a decision made under pressure.

Related reading

Frequently asked questions

What must be on the risk list?

Capsular contracture, rupture that is often silent, and the likelihood of further operations over a lifetime. Infection, bleeding, fluid collection, wound problems, altered nipple sensation, scarring, asymmetry and dissatisfaction with size. The risks of anaesthesia. And the rare but serious complications, including the rare lymphoma associated with implants.

Is there a risk I might not be told about?

Sometimes, and it is usually a rare one. A complete consent conversation covers the complications that are expected over a lifetime and the rare ones that are serious, however unlikely. If a discussion covers only the first few weeks, ask specifically about what can happen to a device over many years.

What does informed consent actually require?

That you know what is being done, what the realistic alternatives are, what the complications are and how likely each is to affect you, and what happens if something goes wrong. It is a conversation rather than a signature, and you are entitled to take time, ask again, and change your mind before the operation.

Risks & Limitations

  • Breast implants are not lifetime devices: exchange at some point in life is likely rather than exceptional, and should be planned for.
  • Capsular contracture can make the breast firm, painful or changed in shape, and may require surgery; it can recur after treatment.
  • Rupture can occur and is often silent with gel implants, which is why periodic imaging surveillance is recommended.
  • Textured implants carry a small, well-documented association with a treatable lymphoma of the capsule.
  • Changes in nipple and breast sensation are common and may be permanent; breastfeeding cannot be guaranteed after any route.
  • Rippling, visible implant edges and malposition occur more readily in thin patients and with larger implants.
  • Fat transfer carries partial resorption of the grafted fat, oil cyst formation, and an unpredictable final volume.
  • Infection, blood or fluid collections, permanent scars, and venous thromboembolism can occur; prevention of clot is part of the plan.
  • Symmetry is never perfect and no specific cup size or result can be guaranteed.

When to Seek Care

  • Chest pain, shortness of breath or a swollen, painful calf — possible clot; seek emergency care immediately.
  • Fever, spreading redness, warmth or discharge from a wound, or a breast that becomes hot and painful.
  • One breast suddenly changing shape, becoming markedly firmer, or developing a new lump.
  • Persistent swelling or fluid around an implant, or a wound that will not close.
  • Any new breast lump, skin change or nipple discharge — assess it clinically rather than attributing it to the implant.

References & Further Reading

  • American Society of Plastic Surgeons (ASPS) — guidance on aesthetic surgery and patient safety
  • International Society of Aesthetic Plastic Surgery (ISAPS) — international practice standards
  • National Institute for Health and Care Excellence (NICE, UK) — relevant clinical guidance

Medically reviewed by Tongchun Mao, MD (毛彤春), Deputy Director & Head of Aesthetic Surgery. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.